Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.74%11.8B | -9.88%11.27B | -10.20%2.77B | -17.04%2.91B | -8.23%2.77B | -2.55%2.81B | 0.74%12.5B | 3.10%3.09B | 12.17%3.51B | -3.03%3.02B |
| Cost of revenue | 1.19%7.26B | -4.52%7.17B | -10.14%1.76B | -14.77%1.81B | 1.84%1.81B | 8.45%1.8B | 5.92%7.51B | 10.32%1.96B | 22.29%2.13B | -2.20%1.77B |
| Gross profit | 10.97%4.54B | -17.95%4.09B | -10.31%1.01B | -20.54%1.1B | -22.53%966.62M | -17.40%1.01B | -6.17%4.99B | -7.39%1.13B | -0.51%1.38B | -4.19%1.25B |
| Operating expense | 2.80%3.62B | 6.06%3.53B | 18.02%969.95M | 8.66%870.75M | 2.14%870.88M | -4.04%813.92M | 1.95%3.32B | -0.63%821.87M | 0.19%801.32M | 7.24%852.64M |
| Operating profit | 61.75%916.48M | -65.93%566.61M | -85.68%44.22M | -60.81%227.67M | -75.77%95.74M | -47.37%198.97M | -19.05%1.66B | -21.58%308.88M | -1.45%580.95M | -22.11%395.17M |
| Net non-operating interest income (expenses) | 40.71%19.72M | 75.98%14.02M | 9.65%3.52M | 12.50%3.56M | 43.42%3.55M | 482.71%3.39M | 310.60%7.97M | 491.83%3.21M | 451.22%3.16M | 351.37%2.48M |
| Non-operating interest income | 31.41%21.1M | 42.01%16.05M | 2.89%3.98M | 1.80%4.02M | 16.89%4.07M | --3.98M | 376,700.00%11.3M | 386,900.00%3.87M | --3.95M | 174,000.00%3.48M |
| Non-operating interest expense | -32.61%1.37M | -39.02%2.04M | -30.14%459K | -40.96%467K | -48.41%519K | -33.22%591K | -11.78%3.34M | -19.98%657K | -12.11%791K | 1.93%1.01M |
| Net investment income | 92.17%-1.33M | -112.47%-279K | 124.90%1.19M | 88.77%-1.34M | 63.50%-904K | -435.31%-16.93M | 256.72%2.24M | -200.06%-4.8M | -11.9M | |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -205.42M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 100.43%8K | -36.37%-1.84M | -26.07%-1.7M | -139K | -55.17%-1.35M | -812.16%-1.35M | 0 | |||
| Less:Other special charges | -100.43%-8K | 36.37%1.84M | --1.7M | ---- | ---- | ---- | 55.17%1.35M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 154.35%15.42M | 612.34%6.06M | -33.77%-4.5M | 249.04%620K | 302.77%5.67M | 259.73%4.27M | -125.72%-1.18M | -753.05%-3.36M | -129.84%-416K | 11.76%1.41M |
| Income before tax | 63.09%951.63M | -59.65%583.52M | -60.40%41.26M | -59.77%232.9M | -73.23%103.62M | -45.27%205.73M | -29.50%1.45B | -73.36%104.2M | -1.61%578.9M | -23.68%387.15M |
| Income tax | 51.42%337.38M | -55.10%222.81M | -42.70%22.78M | -60.73%72.9M | -70.46%41.95M | -33.87%85.19M | -24.78%496.23M | -64.34%39.75M | -7.95%185.66M | -17.19%142M |
| Net income | 70.29%614.25M | -62.03%360.7M | -71.32%18.49M | -59.31%160M | -74.84%61.68M | -51.22%120.54M | -31.74%949.93M | -76.95%64.45M | 1.70%393.24M | -26.99%245.15M |
| Net income continuous operations | 70.29%614.25M | -62.03%360.7M | -71.32%18.48M | -59.31%160M | -74.84%61.68M | -51.22%120.54M | -31.74%949.93M | -76.95%64.45M | 1.70%393.24M | -26.99%245.15M |
| Noncontrolling interests | 1.55%63.39M | -18.79%62.43M | -21.79%16.11M | -32.17%16.11M | -11.20%12.71M | -3.90%17.49M | -6.55%76.87M | 0.32%20.6M | 28.44%23.75M | -17.15%14.32M |
| Net income attributable to the company | 84.68%550.86M | -65.84%298.28M | -94.58%2.38M | -61.06%143.89M | -78.79%48.97M | -54.98%103.05M | -33.32%873.06M | -83.08%43.85M | 0.36%369.49M | -27.52%230.84M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 84.68%550.86M | -65.84%298.28M | -94.58%2.38M | -61.06%143.89M | -78.79%48.97M | -54.98%103.05M | -33.32%873.06M | -83.08%43.85M | 0.36%369.49M | -27.52%230.84M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 84.58%22.15 | -65.82%12 | -94.32%0.1 | -61.04%5.79 | -78.79%1.97 | -55.00%4.14 | -33.33%35.11 | -83.11%1.76 | 0.34%14.86 | -27.48%9.29 |
| Diluted earnings per share | 84.58%22.15 | -65.82%12 | -94.57%0.0956 | -61.06%5.7864 | -78.79%1.9691 | -55.00%4.14 | -33.33%35.11 | -83.11%1.76 | 0.36%14.8589 | -27.52%9.283 |
| Dividend per share | -12.50%14 | 0.00%16 | 0.00%16 | 0 | 0 | 0 | 6.67%16 | 6.67%16 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |